Publications by authors named "Rod Middleton"

Claim this Profile
C
Comparative Responsiveness of Preference-Based Health-Related Quality of Life, Social Care, and Well-Being Measures in the Context of Multiple Sclerosis.
Elizabeth Goodwin, Amy Heather, Nia Morrish, Jenny Freeman, Kate Boddy, Rod Middleton

Value Health· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mediterranean and MIND Dietary Patterns and Cognitive Performance in Multiple Sclerosis: A Cross-Sectional Analysis of the UK Multiple Sclerosis Register.
Maggie Yu, Steve Simpson-Yap, Annalaura Lerede, Richard Nicholas, Shelly Coe, Rod Middleton

Nutrients· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large-scale online assessment uncovers a distinct Multiple Sclerosis subtype with selective cognitive impairment.
Annalaura Lerede, Alexandra Moura, Valentina Giunchiglia, Elisa Carta, William Trender, Rod Middleton

Nat Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
People with multiple sclerosis help design a tool to measure physical functioning and how it affects their daily lives: a plain language summary.
Paul Kamudoni, Dagmar Amtmann, Jeffrey Johns, Karon F Cook, Rana Salem, Rod Middleton

Neurodegener Dis Manag· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review and meta-analysis of Dietary Inflammatory Index and the likelihood of multiple sclerosis/ demyelinating autoimmune disease.
Esmaeil Yousefi Rad, Somayeh Saboori, Thanasis G Tektonidis, Steve Simpson-Yap, Jeanette Reece, Rod Middleton

Clin Nutr ESPEN· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers and strategies to medication adherence amongst people with multiple sclerosis and cognitive problems.
Sarah Thomason, Nima Moghaddam, Nikos Evangelou, Rod Middleton, Roshan das Nair

Mult Scler Relat Disord· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The global patient-reported outcomes for multiple sclerosis initiative: bridging the gap between clinical research and care - updates at the 2023 plenary event.
Paola Zaratin, Sara Samadzadeh, Meral Seferoğlu, Vito Ricigliano, Jonadab Dos Santos Silva, Rod Middleton

Front Neurol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the Pathology, Clinical, and Demographic Characteristics of Younger and Older-Onset Multiple Sclerosis.
Sarah Knowles, Rod Middleton, Benjamin Cooze, Ildiko Farkas, Yeung Yeung Leung

Ann Neurol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations.
Alexander Stahmann, Elaine Craig, David Ellenberger, Firas Fneish, Niklas Frahm, Rod Middleton

Ther Adv Neurol Disord· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
University education facilitates uptake of disease-modifying therapies for multiple sclerosis: A community-based study using the UK MS Register.
Joyutpal Das, David J Rog, Rod Middleton, Jeff W Rodgers, Richard Nicholas

Mult Scler· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring fatigue in people with multiple sclerosis - which questionnaire should be used? A Plain Language Summary of Publication.
Paul Kamudoni, Jeffrey Johns, Karon F Cook, Rana Salem, Sam Salek, Rod Middleton

Neurodegener Dis Manag· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MS care: integrating advanced therapies and holistic management.
Gavin Giovannoni, Helen L Ford, Klaus Schmierer, Rod Middleton, Andrea M Stennett

Front Neurol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe.
Richard Nicholas, Jeff Rodgers, James Witts, Annalaura Lerede, Tim Friede, Rod Middleton

Ther Adv Neurol Disord· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes in multiple sclerosis: a prospective registry cohort study.
Annalaura Lerede, Jeff Rodgers, Rod M Middleton, Adam Hampshire, Richard Nicholas

Brain Commun· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAMS project: a genetic Association study in individuals from Diverse Ancestral backgrounds with Multiple Sclerosis based in the UK.
Benjamin M Jacobs, Luisa Schalk, Angie Dunne, Antonio Scalfari, Ashwini Nandoskar, Rod Middleton

BMJ Open· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early depressive symptoms and disability accrual in Multiple Sclerosis: a UK MS Register study.
Benjamin M Jacobs, Cyrus Daruwalla, Mollie O McKeon, Raghda Al-Najjar, Andrea Simcock-Davies, Rod Middleton

Sci Rep· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing evidence-based guidelines for the safety of symptomatic drugs in multiple sclerosis during pregnancy and breastfeeding: A systematic review and Delphi consensus.
Priyanka Iyer, Kate Wiles, Azza Ismail, Surabhi Nanda, Katy Murray, Rod Middleton

Mult Scler· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers.
Lars Forsberg, Tim Spelman, Pernilla Klyve, Ali Manouchehrinia, Ryan Ramanujam, Rod Middleton

Mult Scler J Exp Transl Clin· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity.
Steve Simpson-Yap, Ashkan Pirmani, Tomas Kalincik, Edward De Brouwer, Lotte Geys, Rod M Middleton

Neurol Neuroimmunol Neuroinflamm· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of the measurement properties of the PROMIS Fatigue (MS) 8a against legacy fatigue questionnaires.
Paul Kamudoni, Jeffrey Johns, Karon F Cook, Rana Salem, Sam Salek, Rod Middleton

Mult Scler Relat Disord· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatigue in multiple sclerosis: A UK MS-register based study.
Harriet Moore, Krishnan Padmakumari Sivaraman Nair, Kathleen Baster, Rod Middleton, David Paling

Mult Scler Relat Disord· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The validity, responsiveness, and score interpretation of the PROMISnq Physical Function - Multiple Sclerosis 15a short form in multiple sclerosis.
Paul Kamudoni, Dagmar Amtmann, Jeffrey Johns, Karon F Cook, Rana Salem, Rod Middleton

Mult Scler Relat Disord· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of smoking cessation on multiple sclerosis disease progression.
Jeff Rodgers, Tim Friede, Frederick W Vonberg, Cris S Constantinescu, Alasdair Coles, Rod M Middleton

Brain· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of employment among people with Multiple Sclerosis across Europe.
David Ellenberger, Tina Parciak, Waldemar Brola, Jan Hillert, Rod Middleton

Mult Scler J Exp Transl Clin· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between deprivation and the access to disease modifying therapies for multiple sclerosis: An England wide community-based study in the UK MS Register.
Joyutpal Das, David J Rog, Rod Middleton, Jeff W Rodgers, Richard Fry

Mult Scler Relat Disord· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis